Search hospitals > Texas > Austin
Texas Oncology Cancer Center
Claim this profileAustin, Texas 78731
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Ovarian Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Tumors
143 reported clinical trials
10 medical researchers
Summary
Texas Oncology Cancer Center is a medical facility located in Austin, Texas. This center is recognized for care of Breast Cancer, Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Ovarian Tumors and other specialties. Texas Oncology Cancer Center is involved with conducting 143 clinical trials across 146 conditions. There are 10 research doctors associated with this hospital, such as Jason M Melear, Debra Patt, Michael Teneriello, and Vivian Cline, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
BRCA2 positive
Top PIs
Jason M MelearTexas Oncology - Austin Midtown5 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
20 reported clinical trials
35 drugs studied
Debra PattTexas Oncology - Austin Central3 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
14 reported clinical trials
24 drugs studied
Michael TenerielloTexas Oncology - Austin Central4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
12 reported clinical trials
26 drugs studied
Vivian Cline, MDTexas Oncology - Austin11 years of reported clinical research
Studies Colorectal Cancer
Studies Pancreatic Cancer
8 reported clinical trials
21 drugs studied
Clinical Trials running at Texas Oncology Cancer Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Mantle Cell Lymphoma
Gallbladder Cancer
Biliary Tract Cancer
Squamous Cell Carcinoma
Bladder Cancer
Endometrial Cancer
Pill
Giredestrant + Phesgo
for Breast Cancer
This trial is testing whether a combination of two drugs is more effective than one drug for patients with advanced breast cancer. The drugs work by blocking signals that help cancer cells grow. The study focuses on patients whose cancer cannot be cured with surgery or other local treatments.
Recruiting2 awards Phase 311 criteria
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Recruiting2 awards Phase 311 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Texas Oncology Cancer Center?
Texas Oncology Cancer Center is a medical facility located in Austin, Texas. This center is recognized for care of Breast Cancer, Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Ovarian Tumors and other specialties. Texas Oncology Cancer Center is involved with conducting 143 clinical trials across 146 conditions. There are 10 research doctors associated with this hospital, such as Jason M Melear, Debra Patt, Michael Teneriello, and Vivian Cline, MD.